It’s Not A Fantasy To Think That AIM ImmunoTech Inc (AIM) Has Big Future Potential

AIM ImmunoTech Inc (AMEX:AIM) currently has a daily average trading volume of 568.27K but it saw 1439867 shares traded in last market. With a market cap of 14.35M USD, the company’s current market price of $0.22 came rising about 2.60 while comparing to the previous closing price of $0.22. In past 52 weeks, the stock remained buoying in the range of price level as high as $0.62 and as low as $0.16. In the recent trading on the day, stock has struck highest price mark of $0.225 while lowest mark touched by it was $0.24.

Taking a look at 20-day trading activity of AIM ImmunoTech Inc (AIM) gives us an average price of $0.2098, while its current price level is -63.71% below from 52-week high level whereas it is 38.21% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $0.2147 while that of 200 days or SMA-200 reads an average of $0.3196. A closer look into the stock’s movement over the week reveals that its volatility is standing at 6.89% during that period while stretching the period over a month that increases to 9.63%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 55.25 which implies that the stock is in neutral territory.

Over the week, AIM’s stock price is moving 17.25% up while it is 14.80% when we observe its performance for the past one month. Year-to-date it is 13.64% up and over the past year, the stock is showing a downside performance of -46.44%.

Currently, AIM ImmunoTech Inc’s total number of outstanding shares is 58.67M with 8.57% of that held by the insiders while 14.07% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -686.04% and return on equity (ROE) at -187.58%. Stock’s beta reads -0.29. Stock has a price to book (P/B) ratio of 4.53 while price to sale or P/S ratio amounts to 75.53. Its return on asset (ROA) is -115.46% on average.